Lonza | LONN - Net Income



Lonza reported CHF307M in Net Income for its fiscal semester ending in December of 2024.


Net Income Change Date
Akzo Nobel EUR 124M 17M Jun/2025
Alcon AG USD 176M 174M Jun/2025
Almirall EUR 26.58M 4.98M Jun/2025
AstraZeneca USD 2.45B 466M Jun/2025
BASF EUR 79M 729M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Beiersdorf EUR 552M 222M Jun/2025
Covestro EUR -59000000 101M Jun/2025
Demant DKK 1.12B 71M Jun/2025
Fresenius EUR 330M 101M Jun/2025
Fresenius Medical Care EUR 225M 74M Jun/2025
Geberit CHF 187.3M 37M Mar/2025
Genmab DKK 336M 141M Jun/2025
Givaudan CHF 294M 150M Jun/2024
GlaxoSmithKline GBP 1.44B 181M Jun/2025
GN Store Nord DKK 165M 94M Jun/2025
Hikma Pharmaceutical USD 133M 93M Dec/2024
Johnson Matthey GBP -111000000 595M Mar/2025
Merck EUR 652M 83M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Philips EUR 240M 165M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Sanofi EUR 3.94B 2.07B Jun/2025
Sika AG CHF 287.95M 362.95M Jun/2024
Smith & Nephew USD 293M 95M Jun/2025
Solvay EUR 9M 72M Jun/2025
UCB EUR 857M 649M Dec/2024